Roquette aims to up its biologic reagent presence

By Staff Reporter

- Last updated on GMT

Image: iStock/K-Kwanchai
Image: iStock/K-Kwanchai
Roquette says investments in packaging, documentation and testing requirements have helped the firm move into the biologics excipient and reagent space.

Traditionally a small molecule drug raw ingredient and excipient supplier, Roquette has upped its position in the biopharmaceutical space and now offers dextrose for cell energy in the upstream process, and protein stabilisers in the downstream.

“We recognise the importance of biopharmaceuticals for diseases that were once thought impossible to treat or cure,”​ Roquette global market manager, BioPharma Carol Smith told Biopharma-Reporter.com.

“Just as the market is evolving, we are prepared to partner and collaborate with customers to advance the future of medicine.”

While the firm has supplied the biopharma industry for a number of years through repackages,

Roquette’s move into biologics has been helped by its knowledge about carbohydrates and their effect on cell growth, she continued, adding the firm is making “meaningful investments”​ to serve the Biopharma market

“We have been preparing for this by investing in new packaging, higher documentation, and additional testing requirements,”​ she said.

“Biopharma customers need to have access to technical information to make informed decisions to manage risk; we have prepared several technical packages to make it easier for them.”

The firm has three products available to clients – Lycadex glucose, Pearlitol mannitol and Neosorb sorbitol – but intends to increase its portfolio.

“We will continue to build the portfolio with additional products and services and ensure that our capabilities are aligned with our customer’s growth,” ​said Smith.

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars